Home | Welcome to Contract Pharma   
Last Updated Friday, May 22 2015

Print

Topics - Drug Discovery


Refine by Date:
From: To:
Published May 21, 2015
Acquires exclusive worldwide rights to SMC technology for research applications Read More »
Published May 19, 2015
Will evaluate combinations of Advaxis’s Lm-LLO immunotherapy technology and Sorrento’s immunomodulatory antibodies Read More »
Published May 14, 2015
Will combine biotech capabilities to develop therapies for autoimmune disorders Read More »
Published May 12, 2015
Will collaborate to identify and validate tumor targets and corresponding TCRs in cancer Read More »
Published May 11, 2015
Firms will co-develop Elasmogen's soloMER technology Read More »
Published May 8, 2015
Beeler brings15 years of experience in the life sciences Read More »
Published May 7, 2015
Will combine biotech capabilities to develop therapies for autoimmune disorders Read More »
Published May 7, 2015
Combines two next-gen discovery platforms Read More »
Published April 30, 2015
Early Discovery acquisitions contribute to growth Read More »
Published April 15, 2015
Will provide discovery and development services from gene to candidates and beyond Read More »
Published April 14, 2015
Batra to lead the combined life science business Read More »
Published April 9, 2015
Will repurpose assets for orphan diseases Read More »
Published April 7, 2015
Enter into license agreement on novel small molecules targeting mTORC1 activation Read More »
Published April 2, 2015
Change over will become official on April 13 Read More »
Published March 26, 2015
Evotec will screen several ion channel targets Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On